why choose us

First received: November 21, 2023

Clinical Trial: A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostatic Neoplasms

Study Type: OBSERVATIONAL


Official Title: Novel Hormonal Therapy (NHT) for Treating Patients With Metastatic Castration-Sensitive Prostate Cancer (mCSPC): An Analysis of National Veterans Affairs Health Care Network Data

Brief Summary: The purpose of this study is to learn about- for how long are NHTs taken by men to treat mCSPC.NHTs in this study include study medicines:abiraterone,apalutamide,enzalutamide.Prostate cancer is one of the most common cancers in men.The prostate is a gland in the male body that helps make semen.Metastatic cancer is a cancer that has spread to other parts of the body.Most prostate cancers need male hormones to grow.When cancer cells respond to treatment that lowers male hormones, this is known as…

Read more